Origin Bio
Origin Bio maps cancer biology in real tumors by generating multimodal datasets from patient tissue, including spatial transcriptomics, morphology, proteomics, and ex vivo perturbation response data.
About Origin Bio
Creating the largest patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies. These datasets are unique as they screen the effects of various drugs and genetic medicines under the control of our DNA switches.
Products
An AI model that generates regulatory DNA elements and predicts their function in three cell types.
A tissue-first data and model engine that generates spatially resolved maps of cell states, programs, and niches from patient tumor samples.
Security and compliance
No security details published yet
Origin Bio hasn't published certifications or security practices that we could find. Ask their team for audit reports.
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Origin Bio